Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortSteroidal aromatase inhibitor for hormone-positive breast cancer.Aromatase inhibitor for breast cancer treatment and prevention.
Body systemCancerCancer
Drug classAromatase inhibitorsAromatase inhibitors
SupplyPrescription onlyWHO essential medicinePrescription onlyWHO essential medicine
Main usesHormone-receptor-positive breast cancer after menopauseBreast cancer after menopause, Breast cancer prevention (high risk)
How it worksLowers oestrogen that fuels breast cancer.Cuts oestrogen levels after menopause.
Starts workingDepends on the cancer and regimen—
Half-lifeAbout 24 hoursAbout 50 hours
Typical adult doseDosed by your cancer team according to the treatment protocol.1 mg once a day.
FormsTabletTablet
Common side effectsHot flushes, Joint pain, Tiredness, Sweating, InsomniaHot flushes, Joint pain, Tiredness
Serious side effectsBone thinning, Liver enzyme riseBone thinning, Severe skin reactions (rare)
Don't take ifPremenopausal women (unless ovarian suppression); Pregnancy—
AlcoholUsually no problem in moderation. No specific interaction.—
PregnancyUsually avoidedNot for pregnancy.Usually avoidedNot for use in pregnancy.
BreastfeedingUsually avoidedAvoid.—
In use since—1995
Brand namesUnited States: AromasinUnited Kingdom: AromasinIndia: Aromasin, Exemestane (generic)United States: ArimidexUnited Kingdom: ArimidexIndia: Armotraz, Altraz
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H—
ATC codeL02BG06L02BG03

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker